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multiple science categories. 
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“Therapy should be permanently backed up by scientific research without which no 
progress is possible. Moreover, the search for pure knowledge is one of the important 
needs of mankind.”
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ABSTRACT
Humans and animals acquire the parasite Toxoplasma gondii through contaminated food 
or water, upon which the parasite rapidly disseminates in the host. In immunocompetent 
individuals, this acute phase is transient and leads to chronic colonization of preferentially 
the central nervous system (CNS). The latent chronic infection may reactivate in 
immunocompromised individuals, causing potentially lethal encephalitis. It has been 
established that dendritic cells (DCs) are exploited by T. gondii as “Trojan horses” to 
facilitate dissemination in the host. T. gondii infected DCs exhibit a hypermigratory 
phenotype that is a major determinant for enhanced dissemination of the parasite. The 
host cell pathways involved in the onset and maintenance of this phenotype are largely 
unknown. This thesis has investigated potential mechanisms of host cell subversion, 
addressing dissemination during the acute phase of infection and reactivated infection 
in the brain upon immunosuppression. The main findings of the thesis are listed below.
Significant CD8+ T cell infiltration and activation of CNS resident microglia and astrocytes 
was observed in close vicinity of reactivated T. gondii foci in mouse brain. Cortical microglia 
exhibited hypermigration upon T. gondii infection in vitro, as previously shown for DCs. 
Infected microglia and astrocytes showed increased sensitivity to T cell mediated killing, 
allowing parasite transmission to surrounding cells. Thus, resident and infiltrating cells 
may act as Trojan horses, potentiating local T. gondii dissemination in the encephalitic 
brain.
We developed a motility assay in which cells are tracked while migrating in a collagen 
matrix. In this assay, T. gondii infected DCs displayed increased velocities as early as 
10 min post invasion. This “hypermotility” coincided with the redistribution of actin 
and integrins. Infected DCs also chemotaxed along a gradient of CCR7 ligand CCL19. 
Collectively, this series of cellular events contributes to a shift in the migratory capacity of 
T. gondii infected DCs, expanding the concept of the hypermigratory phenotype.
We showed that DCs express functional γ-aminobutyric acid (GABA) receptors and are 
capable of producing and secreting GABA. T. gondii infection enhanced GABA secretion, 
while inhibition of GABA production, transport or GABA receptors abolished the 
hypermigratory phenotype. This autocrine GABAergic activation was crucial for DCs to 
act as Trojan horses in T. gondii dissemination in vivo. 
This thesis describes the expression of the voltage dependent Ca2+ channel CaV1.3 in murine 
DCs. We found that GABAergic activation was linked to CaV1.3 and that selective blockade 
or knockdown of the latter abolished T. gondii induced hypermotility in DCs. This fast-
acting signaling axis may allow rapid parasite manipulation of host cell migration.
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In summary, we have shown that T. gondii exploits non-canonical migration-related host 
signaling pathways to enhance its dissemination. Several cell types are likely involved as 
Trojan horses at different stages of the infection process, e.g. DCs, T cells and microglia. 
This work also illustrates that the study of parasite-host interactions may further our 
understanding of basic cellular mechanisms, such as motility, and uncover novel signaling 
pathways in the host.
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POPULÄRVETENSKAPLIG 
SAMMANFATTNING
Toxoplasma gondii är en intracellulär parasit som kan infektera alla varmblodiga djur, 
inklusive uppskattningsvis 30 % av världens befolkning (15-25 % i Sverige). Parasiten 
sprids genom smittad mat eller vatten och orsakar potentiellt livslång latent infektion i 
hjärnan. De flesta upplever milda till obefintliga symptom vid smittotillfället men personer 
med nedsatt immunförsvar riskerar att drabbas av livshotande toxoplasmos i hjärnan. Att 
smittas under graviditet innebär också risk för att parasiten infekterar fostret, vilket kan 
leda till missfall eller allvarliga fosterskador.
Vi studerar de tidiga stadierna av infektionsförloppet då parasiten sprids i kroppen och 
når viktiga organ som hjärnan och livmodern. Under denna fas infekterar parasiten 
bl.a. vita blodkroppar (immunceller) och använder dem som ”trojanska hästar” för att 
färdas i kroppen på ett snabbare och säkrare sätt. Toxoplasma manipulerar cellerna 
och förmår dem att röra sig fortare (bli ”hypermigratoriska”), vilket kräver sofistikerad 
kommunikation mellan parasit och värdcell. Det senare skulle sannolikt kunna utgöra 
en angreppspunkt för behandling av Toxoplasma-infektion. Målet med min avhandling 
har varit en mer detaljerad beskrivning av spridningsförloppet vid akut infektion och i 
den immunnedsatta hjärnan, med fokus på värdcellers rörelseförmåga och intracellulära 
kommunikation.
Vi har tidigare modellerat sjukdomsförloppet vid immunnedsättning hos en bärare av 
Toxoplasma med hjälp av möss som behandlats med ett kortison-besläktat preparat. I 
modellen blossar den latenta infektionen upp, vilket orsakar kraftig inflammation i hjärnan 
och attraherar immunceller till platsen. I den föreliggande studien visade vi att en grupp 
celler nära den aktiva infektionen i hjärnan, s.k. mikroglia, också blev hypermigratoriska 
när de infekterades. När immunceller förstörde Toxoplasma-infekterade celler undkom 
parasiten för att sedan infektera själva immuncellerna, vilket potentiellt bidrar till 
parasitens spridning.
Vi har visat att ett signalsystem som hämmar signalöverföring i hjärnan, det s.k. GABA-
systemet, även används av de immunceller vi studerar. GABA:s fysiologiska funktioner i 
dessa celler är fortfarande okända men våra resultat indikerade att systemet utnyttjas av 
Toxoplasma för sin spridning. Blockering av systemet hämmade infekterade immuncellers 
rörelseförmåga och samma blockering ledde i våra djurförsök till fördröjd spridning av 
parasiten i värddjuret. 
I en detaljerad undersökning av immunceller direkt efter kontakt med parasiter, kunde 
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vi se att cellerna radikalt ändrade sitt utseende och rörelsemönster inom 10 minuter efter 
infektion. Denna tidsrymd kan jämföras med immuncells-aktivering vid inflammation 
som är i storleksordningen timmar, eftersom cellens uttryck av gener förändras. Transport 
av information i celler kan även ske i form av flöden av molekyler och joner. Genom att 
visualisera dessa flöden i immunceller identifierade vi en ny jonkanal med koppling 
till GABA-systemet. I likhet med detta ledde blockering till förlust av rörelseförmåga 
hos infekterade immunceller. Aktivering av jonkanaler kan innebära mycket snabb 
intracellulär överföring av information, vilket stämmer överens med att immuncellerna 
reagerade snabbt på Toxoplasma-infektion.
Sammanfattningsvis har vi visat att Toxoplasma utnyttjar intracellulär kommunikation 
för att förändra sina värdcellers beteende och sannolikt öka sina möjligheter till överlevnad 
och spridning. Vi kan också konstatera att våra studier lett oss till upptäckten av en ny 
signalväg i immunceller som kan utgöra en hittills outforskad länk mellan hjärnan och 
immunförsvaret. Att undersöka en parasit som utvecklats tillsammans med däggdjur 
under miljontals år kan därmed vara en viktig källa till kunskap om oss själva.
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AIMS OF THE THESIS
Main hypothesis 
Toxoplasma gondii modulates motility-related host cell signaling to disseminate in the 
organism.
The work has been carried out according to 3 specific aims:
1) To further characterize T. gondii infected immune cells and their role in parasite 
dissemination during acute and reactivated infection in vitro and in vivo.
2) To investigate the role of GABAergic signaling in dendritic cells in relation to T. gondii 
infection and the hypermigratory phenotype.
3) To study the role of Ca2+ signaling in dendritic cells infected by T. gondii, specifically 
focusing on migratory mechanisms.
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AIDS  Acquired Immunodeficiency Syndrome
ALCAM  Activated Leukocyte Cell Adhesion Molecule
Arp  Actin Related Protein
ATP  Adenosine Triphosphate
BBB  Blood Brain Barrier
CaV  Voltage Dependent Ca2+ Channel
CCL  C-C Motif Chemokine
CCR  C-C Chemokine Receptor
CD  Cluster of Differentiation
CDC  Cell Division Control Protein
CNS  Central Nervous System
CRAC channel Ca2+ Release-Activated Ca2+ Channel
CXCL  Chemokine (C-X-C motif) Ligand
DC  Dendritic Cell
DNA  Deoxyribonucleic Acid
ECM  Extracellular Matrix
EGFR  Epidermal Growth Factor Receptor
ELISA  Enzyme-Linked Immunosorbent Assay
ER  Endoplasmic Reticulum
ESA  Excreted-Secreted Antigens
Fln  Filamin
GABA  γ-Aminobutyric Acid
GAD  Glutamate Decarboxylase
GAT  GABA Transporter
GPCR  G-Protein Coupled Receptor
GPI  Glycosylphosphatidylinositol
GRA  Dense Granule Protein
GTP  Guanosine Triphosphate
HIV  Human Immunodeficiency Virus
HSPC  Hematopoietic Stem and Progenitor Cell
ICAM  Intercellular Adhesion Molecule
IFN  Interferon
IL  Interleukin
iNOS  Inducible Nitric Oxide Synthase
IP3  Inositol Trisphosphate
IVIS  In Vivo Imaging System
LFA  Lymphocyte Function-Associated Antigen
LPS  Lipopolysaccharide
LIST OF ABBREVIATIONS
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MAPK  Mitogen Activated Protein Kinase
MHC  Major Histocompatibility Complex
MIC  Microneme Protein
MMP  Matrix Metalloproteinase
MyD88  Myeloid differentiation primary response gene (88)
NF-κB  Nuclear Factor κB
NK cell  Natural Killer cell
PGE  Prostaglandin E
PIP2  Phosphatidylinositol 4,5-bisphosphate
PKC  Protein Kinase C
PV  Parasitophorous Vacuole
RON  Rhoptry Neck Protein
RyR  Ryanodine Receptor
shRNA  Short Hairpin RNA
TLR  Toll-Like Receptor
RNA  Ribonucleic Acid
SDF  Stromal Cell Derived Factor
SOCE  Store-Operated Ca2+ Entry
STIM  Stromal Interaction Molecule
TH  T Helper Cell
TNF  Tumor Necrosis Factor
TRPM  Transient Receptor Potential Melastatin
VCAM  Vascular Cell Adhesion Molecule
VDCC  Voltage Dependent Ca2+ Channel
WASp  Wiscott-Aldrich Syndrome Protein
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 171) Dendritic Cell Migration in Health and Disease 
1) DENDRITIC CELL MIGRATION IN 
HEALTH AND DISEASE 
Since their initial description in lymphoid organs (278), dendritic cells (DCs) have been 
recognized as a vital component of the immune system. DCs exhibit a unique combination 
of immune surveillance and migratory capacity. By identifying potentially dangerous 
agents and initializing an immune response, DCs mediate a link between the innate and 
adaptive immune system (46). Below, some key aspects of DC functions are introduced, 
with an emphasis on the role of migration in these processes.
1.1) The Role of DCs in the Immune Response 
There is considerable heterogeneity among DCs and several ways of categorizing different 
subsets have been proposed. Based on lineage, a distinction can be made between 
conventional DCs, including tissue resident subsets, and non-conventional DCs, e.g. 
inflammatory DCs (153). Tissue residing DCs, e.g. in gut mucosa and skin, sample the local 
environment by pinocytosis (soluble antigens), or phagocytosis (non-soluble antigens) 
(85, 207, 277). Inflammatory DCs derive from monocytes and are recruited to sites of 
inflammation where they perform similar functions as tissue resident DCs (268). 
DCs express a broad range of pattern recognition receptors, e.g. Toll-like receptors 
(TLRs) and nucleotide-binding and oligomerization domain (NOD)-like receptors, which 
recognize conserved molecular patterns associated with infection and tissue damage. 
Well studied examples include gram-negative bacterial lipopolysaccharide (LPS, TLR4) 
and double stranded or endogenous RNA (TLR3) (48). TLR triggering induces transient 
DC arrest and enhances uptake of antigen (87), which is then processed to peptides and 
presented on the cell surface on major histocompatibility complex (MHC) molecules. 
DCs having undergone this process are commonly referred to as “mature” and will leave 
the periphery, enter the lymphatics and migrate to secondary lymphoid organs (62). T 
lymphocytes (T cells) that have not been exposed to antigen circulate continuously and 
encounter mature DCs in the lymph nodes, whereupon antigen loaded MHC molecules 
interact with T cell receptors (202). Recognition of a presented peptide by the T cell 
receptor in this “immunological synapse”, along with DC co-stimulatory signals such 
as CD86 and CD40, induces differentiation into effector T cells. Generally, exogenous 
antigens are loaded on MHC class II and presented to CD4+ T cells and endogenous 
antigens are presented on MHC class I to CD8+ T cells (125). Presentation of exogenous 
antigens on MHCI, so-called cross-presentation, can also occur (259). 
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1.2) Migratory Activity of DCs
Migration can be considered a hallmark feature of DCs, as several of their core functions 
(e.g. antigen sampling and trafficking to lymph nodes) depend on motility. As such, 
migration is a highly regulated process that adapts to external and internal factors (244). 
All motile cells polarize along the axis of migration, extending a ‘leading edge’ in the 
direction of movement and retracting the ‘trailing edge’ at the opposite end. Mechanisms 
of cell migration can be situated on a scale between adhesion-dependent (mesenchymal) 
and adhesion-independent (amoeboid) locomotion (126, 164). The integrin family of 
transmembrane receptors is a major contributor to cell adhesion and adhesion-mediated 
signal transduction. They are heterodimers of one α subunit (18 described) and one β 
subunit (8 described) (127). Binding specificity is determined by the subunit composition 
and includes components of the extracellular matrix (ECM) and surface receptors on other 
cells (126). Integrins are anchored to the intracellular actin-binding proteins talin and 
filamin (Fln), providing a direct link between extracellular stimuli and the actin cytoskeleton 
(52, 204).
Mesenchymal migration operates by consecutive cycles of attachment and detachment, 
during which the cell exerts force on the extracellular substrate in order to move along or 
penetrate through it. Cell attachment and force transmission is mainly through integrins 
(260). Podosomes are transient actin bundle structures that are considered focal points of 
cell-ECM interactions, degradation and invasion in DCs, macrophages and other myeloid 
cells. They coordinate several actin-related proteins and integrins in a ring around the 
actin core with a diameter of about 500 nm and a half-life of 10 min (307). A recent 
study also proposed a role for podosomes in forming protrusions involved in DC antigen 
sampling (15).
Highly motile cells, such as DCs and T cells, employ amoeboid migration when migrating 
in interstitial tissues. This rapid mode of migration is not proteolytic and depends less on 
cell-matrix interactions, being powered by a focused flow of actin (163, 330).  The type of 
migration employed depends on the extracellular environment and activation status of the 
cell. Lämmermann and colleagues have shown that long-distance interstitial DC migration 
does not depend on integrins, in contrast to cell surface attachment, crossing of tissue 
barriers and concerted cell movement (162, 163, 165). Also, macrophages migrating in a 3D 
matrix employ a podosome-dependent proteolytic mechanism or  podosome independent 
amoeboid migration, depending on the density and composition of the matrix (306).
1.3) Chemotaxis 
Chemotaxis is defined as cell migration directed by gradients of chemoattracting 
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molecules. Many of these are chemotactic cytokines (chemokines), which control the 
migration patterns of various cell types in the body. Chemokine receptors are G protein 
coupled receptors (GPCRs) that relay the directional information encoded in chemokine 
gradients, likely through polarized expression towards the leading edge of migrating 
cells (208). The expression of chemokine receptors is dynamic, as exemplified by DCs, 
where maturation induces down-modulation of C-C chemokine receptor (CCR) 5 and up-
regulation of CCR7 (251), which mediates a switch in chemokine responsiveness (73). As 
a result, CCR7 ligands C-C motif chemokine ligand (CCL) 19 and CCL21 selectively recruit 
mature DCs to secondary lymphoid organs where T cell interactions occur (93, 133, 248, 
255, 322). The expressed set of chemokine receptors thus determines the directionality of 
movement in tissue (135).
1.4) Molecular Mediators of DC Migration
Rho family GTPases cycle between the active (GTP-bound) and inactive (GDP-bound) form 
as important regulators of central cellular processes, most prominently actin dynamics 
(317). Rho GTPases Cdc42, Rac1 and Rac2 play important roles in chemotaxis (7, 295, 
321) and it was recently shown that DC trafficking to lymph nodes in vivo is abolished 
in Cdc42-/- cells (165). It has been proposed that Rac1 and Rho confers directionality 
sensing in chemotaxis while Rac2 and Cdc42 regulate actin dynamics (239, 285). CCR7 
ligation induces RhoA dependent activation of the integrin lymphocyte-associated antigen 
(LFA)-1, inducing a state of high affinity for the ligand intercellular adhesion molecule 
(ICAM)-1 (101). This process has been implicated in leukocyte rolling and diapedesis 
during transendothelial migration (113). Also, DC ICAM-1 binds LFA-1 on T cells during 
immunological synapse formation, increasing interaction affinity and providing an 
additional co-stimulatory signal for T cell activation (147).
At the center of cell migration is the force generation necessary for the dynamic formation 
of membrane protrusions. According to present models, membrane protrusions are 
formed by polymerization of monomeric actin into filamentous (F) actin or by hydrostatic 
pressure caused by contraction of the actin network (115, 155, 166). Actin contraction is 
mainly mediated by type II myosin motor proteins (216), which have been proposed to be 
essential for DC passage through narrow gaps and pores (88, 163). Polymerization of actin 
is catalyzed by Rho GTPase activated nucleation factors, such as formins and the actin-
related protein (Arp) 2/3 complex, producing un-branched and branched actin filaments 
respectively. The polymerization process is precipitated by profiling-mediated recruitment 
and activation of monomeric actin (231). Cdc42 regulates Arp2/3 via activation of Wiskott-
Aldrich Syndrome protein (WASp), which is required for the formation of podosomes 
in macrophages and DCs (39, 174, 186). WASp deficient DCs also display impaired 
migration to lymph nodes and as a result, reduced T cell priming (35, 63). Flns 
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participate in crosslinking actin filaments and Lamsoul and colleagues recently showed 
that FlnA expression increases in DCs upon maturation and is associated with podosome 
formation and proteolytic degradation (167).
The diaphanous-related (Dia) formin mDia1 has been shown to be involved in DC 
transmigration and in vivo chemotaxis (297). In tumor cells, Rho GTPases differentially 
regulate the mode of migration, RhoA promoting an amoeboid contraction dependent 
phenotype while Rac1 is associated with mesenchymal migration (252). mDia1 positive 
feedback on RhoA has also been shown to promote matrigel invasion in a metastasizing 
cell line (146). The relevance of Rho GTPases in the context of infection is illustrated by 
the fact that they are targeted by many bacterial infections including Yersinia, Salmonella, 
Clostridium and Escherichia (139, 169, 242, 312). 
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2) TOXOPLASMA GONDII
Toxoplasma gondii is an obligate intracellular protozoan parasite belonging to the 
apicomplexa family. T. gondii has a broad range of hosts, as any warm-blooded vertebrate 
can serve as intermediate host and it can survive and replicate in virtually any nucleated cell 
(3). It is studied both as a pathogen in its own right and as an important model organism 
for other apicomplexan parasites, such as Plasmodium and Cryptosporidium (145). T. 
gondii is a global zoonotic pathogen, causing infection on all populated continents (217). 
Seroprevalence varies greatly between countries, e.g. 14,0 % in Stockholm, Sweden and 
74,7 % in Recife, Brazil (84, 232).
2.1) Life Cycle and Population Structure
As definitive hosts, felines permit parasite gametogenesis and sexual recombination, 
followed by formation of environmentally stable oocyts, which are then shed with the 
feces. An ingested oocyst will rupture in the small intestine and release sporozoites that 
invade cells of the intestinal epithelium and differentiate into tachyzoites (78). During 
the acute phase of infection, tachyzoites disseminate throughout the host, reaching 
distant and immunopriviledged sites such as the brain, eyes, testes and placenta. This 
dissemination entails the crossing of multiple biological barriers, such as the intestine, 
the blood brain barrier (BBB), the blood-retina barrier and the placenta (18). Tachyzoites 
eventually develop into cyst-forming and slow-dividing bradyzoites (235), which is the 
parasite stage associated with latent chronic infection, and may reside within the host for 
a long period of time (282). Tissue cysts are preferentially formed in the central nervous 
system (CNS) and in muscle tissue, but are also observed in visceral organs. Ingestion of 
tissue cysts by a feline through predation of an infected intermediate host completes the 
life cycle of T. gondii (78).
While T. gondii is the only species assigned to the Toxoplasma genus, early population 
genetics studies identified three dominant clonal lineages (types I, II and III) with distinct 
virulence and species distributions (120, 270). Genotyping has identified type II as the 
most prevalent in human infections (119, 120), although discrepancies have been observed 
in patients with certain clinical manifestations (106, 143). These and similar observations, 
along with analysis of a wider range of host species, has revealed a more complex population 
structure with several “atypical”, and often disease-causing, strains represented in the 
gene pool (326). Still, the canonical three types remain the best characterized and are used 
experimentally to represent some of the genetic diversity within the T. gondii population 
structure. In this thesis, the three types have been represented by the strains RH-LDMluc 
(type I), PTGluc and PRU-RFP (type II) and CTGluc (type III) (69, 116, 222).
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2.2) Toxoplasmosis
Infection via ingestion of tissue cysts in infected meat or oocysts from environmental 
contaminations generally produces mild or no symptoms in otherwise healthy human 
hosts. Likewise, the establishment of the chronic phase is not associated with clinical 
manifestations in immunocompetent individuals (196). However, epidemiological studies 
have linked T. gondii seropositivity to a higher incidence of psychiatric conditions such 
as self-directed violence, violent suicide attempts and schizophrenia (219, 303). The most 
serious clinical outcomes are seen in immunocompromised patients, e.g. AIDS patients or 
organ transplant recipients on immunosuppressive drugs, where latent tissue cysts may 
reactivate in the CNS. The switch from latent bradyzoites to rapidly dividing tachyzoites 
causes potentially fatal toxoplasmic encephalitis (10, 334). Infection during pregnancy 
can result in miscarriage, still birth or, particularly when infected during the first or 
second trimester of pregnancy, congenital toxoplasmosis (196). Congenital infection is 
associated with birth defects such as chorioretinitis, intracranial calcification and other 
CNS abnormalities (112).
2.3) Lytic Cycle
Tachyzoite motility is based on a parasite intrinsic mechanism termed “gliding motility”, 
powered by actin polymerization and a myosin motor protein, which are also necessary for 
host cell invasion (75, 192, 249). Invasion is a multi-step process involving the orientation of 
the tachyzoite apical end towards the host cell membrane followed by sequential discharge 
of secretory organelles termed micronemes, rhoptries and dense granules (40, 199). 
Several microneme proteins (MICs) contain adhesion domains that have been proposed 
to mediate initial generic binding to the host cell (42). Rhoptry neck proteins (RONs) and 
MICs are involved in the formation of a tight junction between the host cell and parasite, 
which the parasite passes through using mainly actinomyosin propulsion (4, 26, 81). This 
“moving complex” forms when RON2 is injected into the host cell membrane, where it 
interacts with apical membrane antigen (AMA) 1 and RONs 4, 5 and 8 (26, 156, 157). 
T. gondii profilin-like protein (toxofilin) has been proposed to contribute to tachyzoite 
invasion by depolymerizing host actin and facilitating entry (70).
Upon active invasion, the parasite establishes an intracellular compartment termed the 
parasitophorous vacuole (PV) that is non-fusogenic due to exclusion of proteins required 
for recruitment of endo/lysosomes (197, 198). However, Zhao and colleagues recently 
demonstrated that even phagocytosed tachyzoites are capable of actively “invading” the 
host cell from the phagolysosome, thus forming a PV (343). The parasite also blocks 
autophagy-mediated degradation by activating the epidermal growth factor receptor 
(EGFR) cascade (201). The PV recruits host organelles such as endoplasmic reticulum 
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(ER) and mitochondria and allows for parasite replication, salvaging of nutrients from the 
host and export of parasite effector molecules that subvert host cell functions (56, 94, 123). 
Parasite egress from the host cell employs several of the molecular mediators involved in 
invasion (118, 269). Permeabilization of the PV membrane and host cell plasma membrane 
is induced, followed by active parasite exit, although the role of gliding motility in natural 
egress is unclear (31). The factors triggering egress are incompletely understood, although 
sensing of host cell ion balance, likely indicative of the extracellular environment, plays 
an important role (98, 179, 191). Egress is also triggered by host cell exposure to CD8+ 
T lymphocyte killing mechanisms, i.e. Fas receptor-Fas ligand interaction or perforin, 
protecting the parasite from immune destruction (227). Tomita and colleagues reported 
that the time between invasion and egress in vivo is considerably shorter than in vitro, 
which was attributed to premature egress induced mainly by inflammatory macrophages 
(302).
2.4) Immune Response to T. gondii
DCs play a key role in immunity against T. gondii as important producers of the pro-
inflammatory cytokine interleukin (IL)-12 (5). Indeed, depletion of DCs abolishes 
IL-12 production during T. gondii infection, severely impairing host survival (176). 
IL-12 promotes a T helper cell type 1 (TH1) response by inducing T cell differentiation 
and stimulating their secretion of interferon (IFN)-γ (344). Early studies identified 
production of IFN-γ as a major protective factor in T. gondii infection (205, 289). Beiting 
and colleagues recently showed that infection with the closely related apicomplexan 
parasite Neospora caninum activates TLR3 and an IFN-α/β response, which is actively 
suppressed in favor of an IFN-γ response during N. caninum/T. gondii co-infection (21). 
Several immune cells contribute to the production of IFN-γ at different stages of T. gondii 
infection, including neutrophils, natural killer (NK) cells and T cells, enhancing growth 
restriction and destruction of intracellular parasites (335). NK cells are also able to kill 
extracellular tachyzoites and infected cells, which however does not appear to significantly 
contribute to parasite control (149). IFN-γ receptor KO mice are unable to control even 
low doses of a low virulent type III parasite, rapidly exhibiting high parasite loads in 
visceral organs and in the brain (69). In mice, toxofilin is recognized by TLR11 and TLR12, 
inducing MyD88 mediated IL-12 production (148, 336). Toxofilin has been implicated 
in parasite motility and invasion and is secreted during these early processes (70, 178, 
229). Additionally, TLR2 and TLR4 are activated by glycosylphosphatidylinositol (GPI)-
linked surface proteins and the endosomal TLR7 and TLR9 by T. gondii RNA and DNA (9, 
64, 200). Humans lack functional expression of TLR11 or TLR12 and as these have been 
considered crucial for parasite control in mice, the details of innate immune detection of 
T. gondii in humans are less well understood (100, 335). 
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Protective immunity against T. gondii is characterized by the maintenance of balance 
between inflammatory and anti-inflammatory mediators. TH1 cells produce auto-
regulatory IL-10, which down-modulates production of inflammatory cytokines (e.g. 
IL-12) by DCs and macrophages (212). IL-10 also protects the small intestine from 
necrosis during T. gondii infection (290). Loss of the TH2 associated cytokines IL-4 and 
IL-33 increase parasite loads and the levels of IFN-γ and pro-inflammatory mediators, 
causing aggravated pathology (138, 241, 292). Production of IL-27 during inflammatory 
conditions of high IL-12 has anti-proliferatory effects that dampen T cell expansion and 
associated pathology (124). Adequate T cell responses are also necessary for long-term 
control of T. gondii latent infection, as seen in depletion studies and in patients with AIDS 
or on immunosuppressive therapy (90, 99, 223). Antibody responses against T. gondii 
contribute to parasite control by blocking parasite invasion and opsonizing extracellular 
parasites, increasing killing by phagocytosis and the complement cascade (57, 254, 310).
T. gondii control in the CNS is dependent on infiltrating immune cells and resident brain 
cells such as microglia and astrocytes (41). Microglia have been described as CNS resident 
macrophages and are involved in homeostatic processes, e.g. tissue remodeling and 
immune functions, e.g. antigen presentation and cytokine production (234). Astrocytes are 
the most abundant brain cell type and form part of the blood brain barrier (BBB, Chapter 
3.2) (329). Neurons, astrocytes and microglia are permissive to parasite proliferation and 
stage conversion in vitro, although in brain tissue, cysts are preferentially found in neurons 
(41, 89, 193). Microglia and astrocytes produce IFN-γ, in addition to infiltrating CD8+ and 
CD4+ T cells observed upon parasite infection in the CNS (286, 319). CD8+ T cell can also 
directly eliminate T. gondii cysts (291). Several resident cell types have been proposed to 
recruit T cells to the infected brain (141). Blood vessel endothelial cells up-regulate ICAM-
1, vascular cell adhesion molecule (VCAM) and MHCII in response to IFN-γ (65). Several 
chemokines are up-regulated in the encephalitic brain, including CCL2 and CXCL10 by 
astrocytes and CCL5 and CXCL9 by microglia. Also, CCL5-expressing leukocytes have 
been observed in close vicinity of T. gondii cysts in the brain (280). IL-10 production 
by microglia and infiltrating T cells contributes to immunomodulation similarly to the 
periphery (66, 258). 
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3) TROJAN HORSE DISSEMINATION OF 
T. GONDII
3.1) Dissemination During Acute Stage Infection (paper III)
The route of dissemination of T. gondii has long been the subject of investigation and 
debate, yet is only partially understood. Extracellular tachyzoites are migratory and can 
penetrate ECM and polarized cell monolayers, which is dependent on MIC2-ICAM-1 
interactions and intrinsic gliding motility (17, 19, 96, 108). The parasite is detected in 
mesenteric lymph nodes, spleen and brain within hours to days of infection via oral, 
intraperitoneal or intragastrical administration (50, 79, 107, 284, 339). Recent work has 
shown that intracellular tachyzoites are the major contributors to dissemination and that 
CD11b+ and CD11c+ cells are parasitized early and to a greater extent relative to other cell 
types (47, 58, 305). Trafficking to secondary lymphoid organs is also a key function of DCs, 
making them a potentially attractive target cell for parasite subversion as a Trojan horse 
(Chapter 2.1). Upon invasion by a T. gondii tachyzoite, DCs exhibit a “hypermigratory 
phenotype” characterized by enhanced transmigration through porous membranes and 
penetration of polarized monolayers, as well as increased parasite dissemination in vivo 
(see Chapter 6.2 for definitions). Infected DCs thus contribute to the shuttling of parasites 
within the host and allow more rapid access to restricted organs such as the brain (160, 
161). Early studies showed that the hypermigratory phenotype is abolished by pertussis 
toxin treatment but is independent of MyD88-mediated TLR activation and signaling via 
chemokine receptors CCR5 and CCR7 (160). This should also be viewed in the context that 
knockouts of TLRs 1, 2, 4, 6 or 9 did not impact parasite loads in mice inoculated with 
extracellular tachyzoites (116). The induction of hypermigration has been confirmed for a 
number of T. gondii isolates belonging to types I, II and III. Interestingly, type II strains 
consistently induced a higher degree of transmigration in DCs than type I strains, type 
III strains being intermediate (161). Also, infection of DCs with N. caninum induces an 
increased rate of transmigration across an in vitro model of the placental barrier, as well 
as potentiates parasite dissemination in vivo (53).
In order to better understand the signaling pathways involved in the onset of the 
hypermigratory phenotype, we resolved to study the early events following parasite 
invasion in DCs. We developed a motility assay where DCs migrate through a collagen 
matrix cast on a chamber slide and are followed by live imaging (Chapter 6.1). Using 
fluorescent parasite lines, cell tracking thus allows differentiation between infected 
and non-infected DCs and monitoring of individual DCs on a time scale of minutes 
post infection. The onset of the hypermigratory phenotype was previously related to an 
increased rate of DCs transmigration at 3 h post incubation with T. gondii (160). We 
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showed that infected DCs display a significantly increased motility as early as 10 min post 
incubation with tachyzoites. In agreement with this finding, the onset and maintenance 
of hypermotility was independent of de novo protein synthesis by the host cell and by 
the parasite, for at least 6 h (Paper III). This suggests that the proteins necessary for a 
rapid migratory response are present in DCs at the point of invasion. Koshy and colleagues 
recently showed that T. gondii is capable of injecting rhoptry proteins into cells it does 
not productively invade (150), however we did not observe any migratory activation in the 
non-infected bystander population. Using the recently described drug 4-bromophenacyl 
bromide (237), we showed that parasite attachment without rhoptry secretion was 
insufficient to induce hypermotility (Paper III). Parasite invasion was thus a requirement 
for hypermotility, in line with previous results that neither exposure to parasite lysate, 
excretory/secretory antigen (ESA), infected DC supernatant or phagocytosis of heat-killed 
parasites is sufficient to induce the hypermigratory phenotype in DCs (160, Paper II, Paper 
III). Collectively, these results indicate that the molecular trigger(s) of hypermotility are 
not secreted prior to invasion and are not present in the extracellular environment.
The onset of hypermotility coincided with a dramatic rearrangement of the DC cytoskeleton, 
including the dissolution of adhesive podosome structures, rounding of the cell body, the 
appearance of veils and displacement of CD18 and CD11c integrins (Paper III). In this 
context, we interpret the cytoskeletal alterations observed in T. gondii infected DCs as 
indicative of a shift in migratory capacity and mode of migration. Indeed, previous reports 
indicate that RhoA dependent loss of podosomes is a prerequisite for fast amoeboid 
migration in mature DCs (39, 308, 309). Podosome dissolution has previously been linked 
to prostaglandin signaling (308) and T. gondii infection in macrophages induces PGE2 
production (221). However, we saw no effect on podosome dissolution or hypermotility 
when DCs were treated with inhibitors of cyclooxygenase, the PGE2 synthesizing enzyme 
(Paper III).
3.2) Chronic Stage and Reactivated Infection (paper I)
Reactivated (recrudescent) toxoplasmosis in the CNS is the most common cause of focal 
brain lesions in patients infected with HIV, leading to significant morbidity and mortality 
(223). In contrast to the acute phase, where peripheral organs carry high parasite loads, 
parasite replication during the recrudescent phase is mainly localized to the CNS (69). 
The CNS is separated from the circulating blood by the BBB, which controls the transport 
of nutrients and signaling molecules as well as trafficking of immune cells. Structurally, 
the BBB consists of the tight junction linked capillary endothelium, surrounded by the 
perivascular ECM of the basement membrane and pericytes. Lining microglia and cellular 
processes from astrocytes and neurons modulate BBB properties, such as permeability 
and transport (Fig 1) (1). Parasite dissemination within the CNS during the recrudescence 
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process is poorly understood, though it is likely of importance for disease progression. CNS 
resident microglia have been proposed to act as Trojan horses in an ex vivo model system 
for CNS infection by Listeria monocytogenes, carrying the bacteria inside the tissue (238). 
Similar observations have been made for monocytes that migrate to the brain in an IFN-γ 
dependent manner (76, 77). During toxoplasmic encephalitis, microglia up-regulate the 
ICAM-1 ligands LFA-1 and macrophage-1 antigen (Mac-1), as well as ICAM-1 itself (67). 
Human immunodeficiency virus (HIV)-1 has also been reported to use a Trojan horse 
mechanism to enter the CNS (211, 225). HIV-1 trans-activator protein induces secretion of 
CCL2 and other chemokines in microglia, eliciting migration through autocrine activation 
of CCR2 (60, 83). This was recently confirmed by overexpression of CCR2 in primary 
microglia (134). These results may also play a role in the T. gondii recrudescence process 
since HIV is a common underlying infection in patients with toxoplasmic encephalitis 
(311). 
In order to study parasite-host cell interactions during recrudescent toxoplasmosis we 
used a combined approach of a mouse model of chronic T. gondii infection and primary 
cultures of glial cells. The recrudescence model is based on chronic infection with a non-
virulent, cyst forming and luciferase expressing strain (CTG luc) of T. gondii. Infection 
progression is monitored through bioluminescence imaging and when the chronic stage 
is reached, the animals are immunosuppressed by dexamethasone treatment (69). The 
distribution of reactivated cysts thus produced resembles those observed in human 
patients (206).
FIGURE 1. Schematic representation of the blood-brain barrier. Transvers (left) and 
longitudinal (right) cross sections are shown. The capillary endothelium is depicted in red, 
astrocytes in blue and microglia in green.
Immunohistochemical analysis of recrudescent brain tissue showed significant activation 
of astrocytes and microglia in and around foci of replicating parasites (Paper I). Given the 
important roles ascribed to these CNS native cells during T. gondii infection (Chapter 2.4), 
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we proceeded to investigate their role in the recrudescence process. To directly assay the 
ability of microglia and astrocytes to function as Trojan horses, we compared their in vitro 
transmigration capacity and observed that microglia responded to infection with increased 
transmigration, as shown for DCs, while astrocytes did not. Infection also enhanced the 
capacity of microglia to penetrate astrocyte monolayers (Paper I). 
Characterizing microglia maturation markers, we showed that T. gondii infection induces 
moderate up-regulation of CD54 (ICAM-1) and MHCI, while expression of co-stimulatory 
CD86 and MHCII was maintained (Paper I). Since IFN-γ is secreted by many cell types, 
including microglia (286), during immune responses against T. gondii (Chapter 2.4), we 
compared maturation marker expression of IFN-γ-stimulated infected and non-infected 
microglia. We observed a down-modulation of the IFN-γ response in the infected cells 
for all four markers as early as 6 h post infection. To establish whether this modulation 
of molecules involved in T cell interactions (Chapter 1.1) affected parasite spread, we 
employed a T cell killing assay. Infected microglia and astrocytes displayed increased 
sensitivity to CD8+ T cell mediated killing, which correlated with increased numbers of 
infected T cells (Paper I). The data suggest that T. gondii escapes the host glial cell targeted 
for killing, only to infect the effector T cell, as previously shown for infected DCs and NK 
cell or T cell mediated killing (51, 226, 227). In accordance with these and previously 
published results (257), we observed recruitment of CD8+ T cells to replicative parasite 
foci, which puts them in close proximity of activated (and potentially infected) microglia 
and astrocytes in the CNS of encephalitic mice (Paper I). 
T. gondii infected microglia display a similar migratory activation as infected DCs, 
suggesting an extension of the Trojan horse concept to this resident CNS cell type, as 
was previously done with macrophages (159). It is tempting to speculate that these 
similarities are connected to the shared origin of microglia, macrophages and DCs in 
myeloid progenitors during embryonal development (102). The results also highlight 
the role of host-parasite interactions in the actual pathology of the infection. Zhang and 
colleagues recently showed that activated microglia significantly contribute to neuronal 
damage during toxoplasmic encephalitis. The neurotoxic activity was connected with the 
production of pro-inflammatory cytokines and induction of iNOS (342). A similar role 
has been described in cell death during neuronal development, where microglia also 
participate in clearance of dying cells and debris (187, 316). T. gondii infection induces NF-
κB dependent matrix metalloproteinase (MMP) secretion in astrocytes, causing fibronectin 
degradation in vitro (181, 182). Release of chemokines and growth factors from dying 
neurons attracts microglia and stimulates phagocytosis (209, 210). Microglia also exhibit 
immunomodulatory activities during chronic and acute T. gondii infection (Chapter 2.4). 
This, in combination with our finding that activated microglia and astrocytes are found in 
close vicinity of foci of replicating tachyzoites (Paper I), suggests that neuronal damage 
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in recrudescent encephalitis is a consequence of a disturbed host-parasite balance, where 
both the parasite and the immune system contribute to tissue destruction.
3.3) DC Chemotaxis in T. gondii Dissemination (paper II and III)
 
The rapid dissemination of T. gondii to secondary lymphoid organs, along with a reported 
link between infection and chemotactic responses in DCs (71) prompted us to investigate 
the role of chemotaxis in the hypermigratory phenotype. We found that DCs chemotax 
along a gradient of CCL19 at 24 h post T. gondii infection, to the same extent as LPS 
stimulated DCs. The velocity at which infected DCs chemotaxed was however significantly 
higher than that of LPS-matured DCs (Paper II), which is in line with previous results 
stating that the hypermigratory phenotype is regulated independently of chemotaxis 
(160). In agreement with these findings, infected DCs also up-regulated CCR7 and down-
regulated CCR5 (Paper II, Paper III). 
Interestingly, a down-modulation of CCR5 was observed in the non-infected bystander 
DCs in the infected population, while these cells did not exhibit chemotaxis or upregulation 
of CCR7 (Paper II, Paper III). It is tempting to speculate that since the down-modulation 
of CCR5 occurs shortly after infection compared to the up-regulation of CCR7 (Paper III), 
they contribute to different aspects of T. gondii dissemination. The loss of CCR5 and the 
onset of hypermotility could allow parasitized DCs to rapidly leave the periphery, while 
CCR7 expression directs them to secondary lymphoid organs, a hot spot of immune cell 
interactions.
It has been known for some time that soluble T. gondii cyclophilin-18 induces chemotaxis 
and IL-12 production in DCs via CCR5 ligation (6). Also, treating DCs with ESA or 
concentrated recombinant T. gondii dense granule protein (GRA) 5 has been shown to 
upregulate CCR7 expression and chemotaxis (72, 224). These events collectively contribute 
to a shift in the migratory patterns of DCs (Chapter 1.2). It is not surprising therefore, 
that the process of altering the chemokine receptor profile in DCs is complex and highly 
controlled, and that the individual steps may be independently regulated.
In summary, we have built on previous observations that DCs become hypermigratory 
upon T. gondii infection, by showing that they also migrate at higher velocities in a 
collagen matrix (hypermotility) (160, Paper III). This migratory activation coincides with 
morphological alterations, including redistribution of actin and integrins, and differential 
expression of chemokine receptors (Paper II, Paper III). Thus, it appears that the 
hypermigratory phenotype progresses over time and that DCs acquire traits at different 
stages of this process, acting in conjunction or synergistically. How each trait specifically 
contributes to parasite dissemination in vivo will be the subject of further studies.
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3.4) T. gondii Dissemination to the CNS
In a detailed investigation of T. gondii infected mice, an increased number of DCs was 
found around plaques of replicating parasites in infected villi in the small intestine, 
while very few DCs were detected inside plaques (105). The authors propose an early DC 
migration wave out of parasite plaques as a potential cause of this observation, which goes 
well in line with our findings concerning the early onset of the hypermigratory phenotype 
of DCs (Paper III). Also, Coombes and colleagues observed influx of neutrophils into the 
small intestine of T. gondii infected mice. When infected, these neutrophils remained 
motile and could carry parasites across the intestinal epithelium into the lumen (55).
While the mechanisms by which tachyzoites enter the CNS are still largely unknown, three 
hypothetical models have been proposed (158): extracellular tachyzoites disseminate 
and traverse of the BBB (i), a Trojan horse is used for transmigrating across the BBB 
(ii) or Trojan horse mediated dissemination is followed by induction of host cell lysis at 
the BBB and extracellular tachyzoite transmigration (iii). Although the involvement of 
(i) and (iii) has not been disproven, much recent investigation has focused on potential 
molecular mediators of (ii) (190). Brain endothelium upregulate ICAM-1 and VCAM-1 
during toxoplasmic encephalitis and IFN-γ stimulation (67, 154). Severity of toxoplasmic 
encephalitis also correlates with increased VCAM-1 and activated leukocyte cell adhesion 
molecule (ALCAM) expression and higher permeability of the BBB (273). In line with this, 
Wang and colleagues have shown that CD8+ T cell recruitment into the CNS is severely 
impaired in T. gondii infected IFN-γ-/- mice, which was rescued with recombinant IFN-γ 
treatment. Also, blocking α4 integrin/VCAM-1 binding abolishes recruitment of CD8+ and 
CD4+ T cells (246, 318). Up-regulation of CCL21 has been observed in filamentous structures 
in the encephalitic brain, associated with CD8+ T cells (328). The putative attraction of 
DCs by these structures was not addressed in this study. Lachenmaier and colleagues 
showed that T. gondii infected antigen presenting cells shuttles parasites across an in vitro 
BBB model and carries parasites to the brain when injected intravenously (154). DCs also 
enter the encephalitic brain through a mechanism dependent on LFA-1 but independent 
of chemokine receptors CCR2, CXCR3, CX3CR1, CCR5 and CCR6 (137). T. gondii infected 
DCs migrate across retinal vascular endothelium in a CAM dependent manner (95). 
Infected monocytes under shear stress have been shown to adhere to and transmigrate 
through human endothelial monolayers in a Mac-1/ICAM-1 dependent manner (109, 
304). T. gondii C18 induces CCR5 dependent macrophage migration and infection with 
a C18 overexpressing T. gondii strain enhanced recruitment to the intraperitoneal cavity 
(128, 129). Infected macrophages also exhibit altered adhesion properties and trafficking 
to mesenteric and cervical lymph nodes (61).
These studies lend support to model (ii), stressing the importance of CAMs, cytokines 
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and chemokines in modulating immune cell trafficking to the CNS. They also indicate the 
potential involvement of immune cell types other than DCs as Trojan horses, e.g. T cells, 
monocytes, macrophages and neutrophils. The contribution of the three hypothetical 
modes of CNS entry awaits thorough in vivo evaluation and may differ with T. gondii 
strains, since the types differ in tachyzoite migratory capacity and induction of the 
hypermigratory phenotype (19, 161).
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4) THE GABAERGIC SYSTEM IN CELL 
MIGRATION
4.1) GABA in the CNS and in the Periphery
γ-aminobutyric acid (GABA) is a small molecule that was initially described as a plant 
metabolite before its role as the main inhibitory neurotransmitter in the CNS was 
discovered in the 1950s (91). Several prokaryotes, e.g. lactic acid bacteria, also produce 
GABA as part of their metabolism (172). GABA is derived from glutamate by the enzyme 
glutamate decarboxylase, stored in vesicles and released by so-called GABAergic neurons 
into the cleft of inhibitory synapses, from where it is cleared by the GABA transporter family 
(GAT) of plasma membrane solute carriers (38, 262). GABA signals through ionotropic 
(GABAA) and metabotropic (GABAB) receptors expressed throughout the CNS. GABAA 
receptors are heteropentameric Cl- channels assembled as combinations of 19 different 
subunits, however only a small subset of the potential combinations are observed in vivo 
(272). GABAB receptors are GiPCRs and thus signal via adenylate cyclase (36). Outside the 
CNS, GABA receptors are found in a variety of compartments, especially endocrine tissues 
including the pancreas, adrenal gland, prostate and uterus (103, 214). Mounting evidence 
also suggest that GABA, and other neurotransmitters such as dopamine, adrenaline, 
acetylcholine, serotonin and glutamate, play important roles in the immune system (170).
4.2) The GABAergic System in Immune Cells
Although the role of GABA as an immunomodulator is not well understood, several 
types of immune cells have been shown to express components of the GABAergic system 
(recently reviewed in (136)). T cells were the first immune cells for which evidence of GABA 
receptor activity was presented (23) and the role of GABA has mainly been investigated in 
the context of T cell activation and proliferation (30, 299, 320). In connection with these 
results, GABA has been implicated in the severity of autoimmune inflammation in models 
of diabetes, multiple sclerosis and rheumatoid arthritis (27, 300, 301). Other studies have 
proposed that macrophages, neutrophils and T cells themselves produce GABA (74, 236, 
281).
GABA/GABA receptor activity has been linked to cell migration in the CNS, where its 
role depends on the mode of migration, cell type involved, stage of maturation and region 
of the brain (185). This complexity is mirrored in the few studies performed so far on 
immune cells, restating the fact that immune cell migration is highly context dependent. 
Neutrophils express GABAB receptors that co-localize with Akt and, when activated, induce 
phosphorylation of Akt and chemotaxis (236). In adult hematopoietic stem and progenitor 
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cells (HSPCs), SDF-1α-induced chemotaxis was blocked by GABA and GABAB receptor 
agonists, which has also been shown for GABAA receptors in monocytes (263, 327). GABA 
itself, however, acted as a chemoattractant for umbilical cord HSPCs (338). The role of 
GABA in DC migration has not previously been addressed.
4.3) GABAergic Signaling in the Hypermigratory Phenotype 
(paper II)
Investigating potential molecular mediators of the T. gondii-induced hypermigratory 
phenotype, we showed by ELISA that murine and human DCs are capable of producing 
and secreting GABA into the extracellular milieu (Paper II). This confirms previous results 
that DCs express GAD65 (27). Upon T. gondii infection we observed up to a 5-fold increase 
in supernatant GABA concentration that was sensitive to inhibition of GAD or GAT. This 
response was observed upon infection with representative strains from types I, II and 
III. No increase in GABA production was seen in the non-infected bystander population 
(Paper II). 
Next, we showed by whole cell patch clamping that DCs respond to GABA by producing 
GABAA receptor currents and that this response is blocked by GABAA specific inhibitors. 
We detected up-regulation of GAT4 at 2 h post infection and increased GABA production 
at 3 h post infection (Paper II), at which time DCs are also hypermigratory (160). In line 
with this observation, blocking the GABAergic activation of infected DCs using inhibitors 
of GABA synthesis, secretion or GABAA receptors abrogated the hypermigratory phenotype 
in these cells. Antagonizing GABAB receptors produced a minute decrease in infected DC 
transmigration, suggesting that GABAA receptor activity accounts for the majority of the 
migratory induction (Paper II). Together with the induction of DC GABA production upon 
infection, this suggested an autocrine/paracrine GABA signaling cascade, similar to what 
has been proposed for neuronal migration (184).
GABA production by DCs should also be viewed in the context of immune cell interactions, 
since it may affect other immune cells expressing GABA receptors, such as T cells (30, 
299). It would be interesting to study the impact of increased DC GABA secretion upon T. 
gondii infection on T cell function, as both cell types are key players in protective immunity 
against the parasite (Chapter 2.2) as well as potential Trojan horses (227, Paper I).
Finally, adoptive transfers showed that GABAergic inhibition of infected DCs abrogated 
the Trojan horse disseminatory advantage in vivo to a similar extent as DC immobilization 
(160, Paper II). This indicates a central role for GABAergic signaling in the hypermigratory 
phenotype.
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MacRae and colleagues recently described a metabolic GABA shunt in T. gondii 
tachyzoites, suggesting that GABA plays a role in the energy metabolism of the parasite 
(183). In accordance with our results (Paper II), the authors did not detect parasite 
secretion of GABA, indicating that the increase in GABA seen in DC supernatant upon T. 
gondii infection is due to stimulated production in the DC itself.
4.4) Cell Motility and Migration – What is the Role of GABA? 
(paper II & III)
Studies evaluating the invasive and metastasizing capacity of cancer cell lines have shown 
both positive (13, 131, 177, 274, 340) and negative (49, 122, 298) effects of GABA receptor 
stimulation. A common feature in these studies is the emphasis on the role of MMPs and 
MAPK activation in invasion and metastasis. Further studies will address the potential 
role of GABAergic signaling in DC MMP activity and invasive capacity. We interpret the 
varying experimental outcomes presented in studies performed on neuronal, immune and 
metastasizing cells as indicative of differential regulation by GABA of different modes of 
cell migration.
The observation that non-infected bystander DCs are not hypermigratory, despite being 
exposed to the same elevated GABA concentration as the infected population (160, Paper 
II) suggests that GABAergic activation is necessary but not sufficient for the T. gondii 
induced hypermigratory phenotype. Accordingly, stimulation of GABA receptors in non-
infected DCs does not significantly alter their transmigration rate. GABAergic inhibition 
reduced the motility of non-infected DCs but not their transmigration capacity (Paper II). 
Also, GABA deprived DCs underwent similar morphological changes as untreated DCs 
upon T. gondii infection (Paper III). These observations implicate parasite subversion of 
separate signaling pathways in DCs, collectively promoting the hypermigratory phenotype. 
This interpretation is corroborated by the rapid onset of hypermotility (Paper III), while 
our data also show that the hypermigratory phenotype is transcriptionally regulated over 
time (Paper II).
We showed that GABAergic inhibition did not abolish directionality in chemotaxing 
infected DCs but reduced the velocity at which they migrated (Paper II). GABA did not 
act as a chemoattractant to naïve, LPS-matured or infected DCs (Paper II), in contrast 
to embryonic neurons, neutrophils and HSPCs (20, 236, 338). These results suggest that 
GABAergic activation and chemotactic signaling are independently regulated but operate 
in conjunction in infected DCs, where the former gives the signal for hypermotility and 
the latter provides directionality of movement. A similar mechanism has been shown 
for gonadotropin releasing hormone-1 neurons, in which GABAA receptors and the 
chemokine receptor CXCR4 interact to guide the neurons to form an organized pattern in 
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the developing brain (43). 
In vivo migration exposes DCs to a complex and dynamic environment, including varying 
concentrations of GABA in different organs and compartments (29, 92), which likely 
requires constant adaptation (Chapter 1.2). The presence of low ambient GABA production 
by non-infected DCs in our in vitro cultures raises the possibility of a concentration 
dependent GABA receptor response. This has been proposed for extrasynaptic GABAA 
receptors in the CNS, where the GABAA channel conductance depends on the extracellular 
GABA concentration (175). It would be interesting to experimentally address the impact 
of varying extracellular GABA concentrations on DC function in organs where GABAergic 
signaling is prevalent, such as the brain or the pancreas.
4.5) GABAergic Activation During Toxoplasmosis
Future experiments will examine whether the GABAergic activation described here is 
generalizable to other cell types and parasite stages. One of the most tempting scenarios 
to explore would be neurons harboring bradyzoites in the chronically infected brain, 
keeping in mind the role of GABA as a neurotransmitter. The ‘fatal attraction’ hypothesis 
proposes that T. gondii actively subverts host innate fear responses in order to increase 
the probability of spread by predation (felines in particular as definitive hosts of T. gondii, 
(323)). Alterations of GABAergic signaling in the brain has been linked to changes in 
mood, anxiety level and fear responses (37, 140, 203). Also, astrocytes produce GABA, 
which reduces secretion of inflammatory cytokines in microglia (168). This, together with 
the fact that microglia exhibit a hypermigratory phenotype upon T. gondii infection (Paper 
I), adds an additional layer to the roles of glial cells during toxoplasmosis. Further studies 
will address whether astrocytes respond to infection with GABAergic activation and the 
potential effects of GABA on microglial migration. Recent microarray data show alterations 
in neurotransmitter and neuropeptide systems in neuroepithelioma cells infected by T. 
gondii (332). While no significant changes in transcription of GABA related genes were 
detected, these systems are also post-translationally regulated (324). Finally, T. gondii 
has been shown to produce dopamine through an endogenous tyrosine hydroxylase, which 
is also detected in brain tissue cysts, and by up-regulating microRNA-132, which alters 
host cell dopamine metabolism (233, 333). Collectively, these results describe a complex 
interplay between the rodent host and the tparasite, which should be further characterized 
in relation to host behavior.
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5) CALCIUM (Ca2+) SIGNALING IN 
IMMUNE CELL FUNCTION
5.1) Ca2+ - A Ubiquitous Second Messenger
The Ca2+ ion is one of the most ubiquitous second messengers in cellular signaling (130). 
Signals are relayed through so called ‘on’ reactions where Ca2+ entry from the extracellular 
space or Ca2+ release from intracellular stores located in the ER cause transient increases 
in the cytosolic Ca2+ concentration ([Ca2+]c). These are then translated into cellular 
responses by Ca2+ sensitive proteins, after which ‘off’ reactions restore the ambient [Ca2+]c 
via ion transporters and pumps (25). The modes of Ca2+ signaling are determined by the 
initiating stimuli and range from singular peaks in [Ca2+]c to oscillatory patterns of specific 
frequencies (275). 
Ca2+ release from intracellular stores and extracellular Ca2+ entry can be triggered by 
multiple kinds of stimuli and are often intertwined. Phospholipase C is activated by GPCRs 
and cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers 
diacyl glycerol and inositol 1,4,5-trisphosphate (IP3). IP3 activates the IP3 receptor in the 
ER, which releases Ca2+ through the receptor pore (195). Intracellular store release can 
also function as amplification of extracellular Ca2+ entry, particularly via Ca2+ sensitive 
ryanodine receptors (RyRs) on the ER (8). Inversely, intracellular stores can activate influx 
of extracellular Ca2+, a process known as store-operated Ca2+ entry (SOCE). The main 
SOCE mediator described is the Ca2+ release activated Ca2+ (CRAC) channel, consisting of 
the Ca2+ binding stromal interaction molecule (STIM) in the ER membrane and the plasma 
membrane Ca2+ channel Orai. When the intracellular stores are released, STIM interacts 
with Orai, which triggers influx of extracellular Ca2+ (24).
5.2) Ca2+ Signaling in Cell Migration 
Cell migration is intimately linked to Ca2+ fluxes through several key signaling pathways 
(260). A gradient of [Ca2+]c is observed along the axis of migrating cells, likely ensuring 
differential activity of Ca2+ dependent effector proteins at the leading edge and rear (261). 
Chemotaxis is a Ca2+ dependent process, since chemokine receptor ligation induces 
influx of extracellular Ca2+ and release of intracellular stores in DCs (218, 256). Similar 
observations have also been made in microglia for CCR5 engagement (114, 265). Blockade 
of Ca2+ permeable transient receptor potential melastatin (TRPM) 2 or the IP3 receptor, 
abolishes DC chemotaxis and homing to lymph nodes (283). Also, potassium channel 
KCa3.1 and Cl- channel Ano6, both of which are Ca2+ induced, are involved in CCR7 mediated 
chemotaxis (264, 296). TRPM4 is a Na+ permeable channel that regulates  [Ca2+]c by altering 
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the electrochemical driving force of Ca2+ entry. Barbet and colleagues showed that loss of 
this regulation in TRPM4-/- mice abrogates DC migration and trafficking to lymph nodes 
(16). TRPM4 deficient mast cells are also deficient in migration and displayed impaired 
actin recruitment (266). Zebrafish primordial germ cells migrate via a plasma membrane 
blebbing mechanism (Chapter 1.2) dependent on local STIM induced [Ca2+] increases 
(32). Microglial podosomes co-localize with several Ca2+ related proteins and inhibition of 
CRAC channels interferes with podosome formation and transmigration (271).
5.3) Membrane Potential and Voltage Dependent Ca2+ Channels
The membrane potential (Em) is defined as the electric potential difference between the 
cytosolic side and the extracellular side of the plasma membrane. Cells maintain an 
electrochemical gradient across the plasma membrane, mainly by active separation of K+ 
and Na+ through the K+/Na+ ATPase, resulting in a high intracellular K+ concentration ([K+]i) and 
high extracellular Na+ concentration ([Na+]e). The resulting unequal distribution of charge 
is known as the resting potential (245). Mathematically, the membrane potential can be 
expressed by the Goldman-Hodgekin-Katz equation for k positively charged monovalent 
ions and l negatively charged:
where R denotes the ideal gas constant, F Faraday’s constant, T the temperature in degrees 
Kelvin and Px the membrane permeability of ion x. Considering only K+, Na+ and Cl- gives:
Decreasing the absolute value of Em below the resting potential is termed “depolarization”, 
while an increase is termed “hyperpolarization”. Experimentally, depolarization of the cell 
membrane can be induced by increasing  [K+]e, which reduces the electrochemical driving 
force of K+ diffusing out of the cell (Fig 1A&B). In excitable cells (neuronal, muscle and 
endocrine cells), Em changes are induced during an action potential, which is the basic 
mode of information transfer in the CNS (245). 
The impact of Cl- channels, e.g. GABAA receptors, on Em depends on the intracellular Cl- 
concentration ([Cl-]i), as has been shown in the developing CNS. In pre-natal neurons [Cl-]i 
is high and triggering GABAA receptors will thus induce Cl- efflux and depolarization (Fig 
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1C), while in mature neurons the reverse is true (Fig 1D). This developmental switch is 
driven by alterations in the Cl- homeostasis of the cells via differential expression of the 
Cl- transporters NKCC1 (Cl- uptake) and KCC2 (Cl- extrusion) (reviewed in (22)), and the 
energy metabolism of the cell (345). 
Voltage-dependent Ca2+ channels (VDCCs) are plasma membrane proteins that respond to 
membrane depolarization by a conformational change that opens the channel (44). VDCC 
nomenclature is based on sequence homology of the pore-forming and voltage-sensing α1 
subunit, grouping them into the 3 subfamilies CaV1, 2 and 3 (82). Expression of VDCCs has 
been considered as a hallmark of excitable cells and has therefore been mostly studied in 
the CNS where the different subfamilies have distinct functions in synaptic transmission 
(45). However, mounting evidence points towards VDCCs, particularly the CaV1 subfamily, 
playing important roles in cells of the innate and adaptive immune system (Table 1), 
although few details are known about their function (288). 
5.3) VDCC Signaling in Immune Cells
Several B cell subsets exhibit CaV1 dependent Ca2+ influx upon ligation of the B cells 
receptor (104, 117). 
Murine CD8+ and CD4+ T cells express CaV1.1, CaV1.2 and CaV1.4, although differential 
expression is observed upon transition from naïve to effector cells (14, 151, 279). CaV1 
expression also varies between T cell subsets, as TH2 polarized cells express a wider 
repertoire than TH1 polarized cells (240, 253). Activation of CaV1 through ligation of the T 
cell receptor is implicated in T cell survival, expansion and homeostasis (213, 240).
Ligation of the mast cell IgE receptor induces a CaV1.2 mediated transient [Ca2+]i increase 
and reduces apoptosis by blocking cytochrome c release (287, 294). TNF-α secretion by 
peripheral blood monocytes is blocked upon inhibition of CaV1.2 and CaV1.3 and CaV1 
activity has been linked to monocyte secretion of apolipoprotein A1 (54, 267).
DC maturation is Ca2+-dependent (59, 86, 314) and blocking CaV1 in human monocyte-
derived DCs inhibits engulfment of apoptotic bodies and IL-12 secretion (230). Curiously, 
CaV1 inhibition in LPS-matured DCs stimulated IL-12 secretion in a MAPK-dependent 
manner (2). DCs also express RyR1, which is activated by CaV1.2 and rapidly stimulates 
MHCII expression (313).
Agonist/antagonist studies have also implicated CaV1 activity in immune functions of 
neutrophils, macrophages, and microglia (12, 114, 243). However, the relevance of these 
results depends on the number of different inhibitors used, inhibitor concentrations and 
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whether antagonist and agonist data concur and should thus be interpreted carefully. Also, 
several well-established VDCC inhibitors have off targets that likely become increasingly 
prominent at higher concentrations (337, 341). 
TABLE 1. VDCC expression on immune cells.
Summary of literature reports of VDCCs identified in immune cells. Methods of 
characterization are abbreviated as Ph (pharmacological), WB (western blot), IF 
(immunofluorescence) and K (gene knockout or knockdown).
 
Cell type CaV1 identified Characterization Function References
Neutrophils Unknown Ph IgG-mediated 
phagocytosis
(243)
NK cells Unknown Ph, WB, FACS Release of 
cytolytic factors
(346)
DCs Human: 1.2
Mouse: 1.3
Ph, WB, IF
Ph, PCR, IF
IL-12 production, 
MHCII expression
DC hypermotility
(230, 313, 
Paper IV)
Monocytes Human: 1.2, 1.3 Ph, PCR, WB TNF-α production (54)
Macrophages Unknown Ph NO/ROS 
production
(12, 132)
Mast cells Mouse: 1.2 Ph, PCR, K Anti-apoptotic (293, 294)
Microglia Unknown Ph CCL5 signaling,
Neurotoxicity
(111, 114)
B cells Rat: 1.3 rat Ph, FACS B cell receptor 
activation
(80, 247)
T cells Human: 1.2, 
1.3, 1.4
Mouse: 1.1, 1.2, 
1.4
Ph, PCR, IF, K NFAT-dependent 
maturation, 
cytokine 
production
(14, 28, 151, 
279)
5.5) Ca2+ and GABAergic Signaling in T. gondii Infected DCs 
(paper IV) 
To investigate the role of Ca2+ signaling in the hypermigratory phenotype, we first showed 
that transmigration and motility of T. gondii infected DCs is severely compromised in the 
absence of extracellular Ca2+. Ni2+ blockade of plasma membrane Ca2+ channels confirmed 
this finding (Paper IV). Known links between GABAergic signaling and VDCCs in the CNS 
(33, 144) prompted us to test whether this concept applies to DCs as well, particularly 
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since VDCCs have not been previously studied in the context of DC motility.
We confirmed VDCC activity on DCs by high KCl-induced depolarization and showed that 
inhibiting CaV1 by nifedipine or verapamil abrogated hypermotility to the same extent as 
GABA deprivation (Paper IV). DCs may thus be an interesting exception to the trend that 
immune cell VDCCs do not respond to artificial depolarization (14, 279, 346). Importantly, 
hypermotility could not be restored by exogenous GABA in DCs where CaV1 was inhibited 
by nifedipine, in contrast to GABA deprived DCs. Next, we showed that KCl restored 
hypermotility in GABA deprived DCs, but again not in DCs where CaV1 was inhibited (Paper 
IV). These data indicate that CaV1 activity occurs downstream of GABA receptor signaling 
and is required for T. gondii induced hypermotility. Inhibition of purinergic receptors 
did not reduce infected DC motility, despite inducing Ca2+ entry when stimulated with 
ATP (250, Paper IV). This suggests that Ca2+ entry through CaV1 specifically is required for 
hypermotility. While we could not directly observe influx of Ca2+ upon stimulation with 
exogenous GABA, the fact that KCl could substitute GABA in restoring hypermotility in 
GABA deprived cells indicates that they stimulate the cell in a similar way (Paper IV). This 
is further supported by previous results that human DCs respond with depolarization to 
KCl and necrotic cell extracts (313). In our hands, measuring total cytosolic Ca2+ changes 
may also lack sufficient spatial resolution and sensitivity to detect the fluctuations we 
propose occur downstream of GABAA receptor activation.
We screened VDCC subtypes by quantitative reverse transcription PCR and found CaV1.3 to 
be predominantly expressed, with all other subtypes being low or undetectable. CaV1.3 was 
also identified by immunofluorescence, whereas staining patterns in T. gondii-infected and 
non-infected DCs did not differ (Paper IV). This is in contrast to human DCs where CaV1.2 
expression has been reported (313), although these share the highest degree of sequence 
homology among CaV1 (82).  To investigate whether CaV1.3 is the functionally dominant 
VDCC in murine DCs, we used a recently described inhibitor with high specificity against 
CaV1.3 compared to other VDCCs (142). Treatment at a concentration recommended for 
optimal CaV1 selectivity (142) abrogated hypermotility and hypermigration (Paper IV). 
We then employed RNA interference using short hairpin RNA (shRNA) packaged in a 
lentiviral delivery system (171). DCs transduced with shRNA targeting CaV1.3 failed to 
become hypermotile upon T. gondii infection, which could not be rescued by addition of 
GABA (Paper IV). While we cannot completely exclude participation of other Ca2+ entry 
pathways, such as SOCE (121), the shRNA data together with the relative specificity shown 
by purinergic receptor inhibition suggest dependence on CaV1.3. We thus conclude that 
Ca2+ is a second messenger to GABAergic signaling in DCs and that CaV1.3 is the major 
contributor to the Ca2+ entry necessary for the hypermigratory phenotype. 
VDCC triggering allows for very rapid signal transduction (11), which is in line with 
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some of the proposed functions in immune cells (Table 1) as well as the rapid onset of 
hypermotility in T. gondii infected DCs (Paper III). Migratory activation has been reported 
in conjunction with cytoskeletal rearrangement in a metastatic breast cancer cell line (97). 
Both of these processes were sensitive to GABA receptor blockage or CaV1 inhibition. 
Further experiments will address whether the T. gondii-induced morphological changes 
in DCs (Paper III) are dependent on CaV1 activity.
Manipulation of host Ca2+ signaling pathways by T. gondii is not a phenomenon unique to 
DCs but has been reported in other cell types. Infection in mast cells was recently shown 
to inhibit antigen-mediated degranulation by reducing Syk kinase phosphorylation of 
PLCγ and thus inhibiting ER Ca2+ release (276). This inhibition requires attachment but 
not invasion of tachyzoites, in contrast to the onset of hypermotility in DCs (276, Paper 
III). Haroon and colleagues have shown that T. gondii infected neurons exhibit altered 
responses to glutamate stimulation and that the majority of neurons that carry cysts in the 
chronically infected mouse brain are functionally silent (110). The authors connected these 
results with behavioral alterations that occur in chronically infected mice, characterized 
by the loss of fear of cat odor (110, 315). In macrophages, Ca2+ signaling is required for 
protein kinase C (PKC)-dependent MAPK signaling and IL-12 expression induced by 
T. gondii (188). Tachyzoite invasion also alters the macrophage Ca2+ signaling pattern 
independently of MyD88 and CCR5 (189). As macrophages exhibit hypermigration upon 
T. gondii infection (159) and likely express VDCCs and GABAA receptors (12, 27), further 
studies will examine whether this pathway is subverted by the parasite in a similar way 
as in DCs. Lin and colleagues recently showed that ectopic expression of T. gondii GRA1 
in a macrophage cell line alters Ca2+ signaling in these cells, providing a potential link 
between parasite invasion and Ca2+ signaling modulation (173). T. gondii is thus capable 
of subverting different host Ca2+ signaling pathways, in order to inhibit cellular responses 
or to enhance them.
Ca2+ signaling in the T. gondii tachyzoite itself has been implicated in several phases of 
the lytic cycle, most notably the invasion process (180, 228). Recently Pace and colleagues 
showed that a transient increase in tachyzoite [Ca2+]c is required for invasion and is partly 
mediated by nifedipine-sensitive entry of extracellular Ca2+ (215). In our experimental 
setup, all Ca2+ signaling inhibitors were added 2-3 h post T. gondii challenge, which reduces 
the probability that the inhibition of hypermotility we observed is due to drug effects on 
the parasites. Thus, we could also show that the GABAergic activated Ca2+ influx upon T. 
gondii infection is necessary not only for the induction but also for the maintenance of 
hypermotility (Paper IV).
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5.6) A Hypothetical Model for T. gondii Induced DC 
Hypermotility (paper IV)
To situate the mechanistic findings presented here in a host-parasite interaction 
perspective, we propose the following model for the GABA-induced Ca2+ signaling upon 
T. gondii infection (Fig 2).
The active invasion of a T. gondii tachyzoite rapidly stimulates GABA synthesis (I), likely 
by GAD65, which is activated by phosphorylation by Ca2+ independent PKC isoform ε 
(324). It remains to be investigated whether T. gondii induces this non-conventional PKC, 
as has been shown for a conventional PKC (188). An alternative hypothesis is that the 
parasite directly activates GAD65 via effector molecules secreted into the host, as several 
of these are active kinases (220).
FIGURE 3. Proposed initial steps of migratory activation of DCs upon T. gondii infection. 
Tachyzoite entry induces GAD dependent synthesis of GABA, which is excreted by GAT. 
Extracellular GABA activates GABAA receptors in an autocrine manner, causing Cl- efflux 
and membrane depolarization. This triggers CaV1.3 dependent Ca2+ entry, which signals a 
shift in migratory capacity.
Next, GAT mediated secretion of GABA into the extracellular environment occurs (II). The 
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rapid upregulation of GAT4 upon infection supports the hypothesis that GABA secretion is 
connected with the onset of the hypermigratory phenotype. Extracellular GABA activates 
GABAA receptors in an autocrine manner (III), causing Cl- efflux, which depolarizes the 
plasma membrane (IV). This triggers voltage sensitive CaV1.3 mediated influx of Ca2+ (V) 
and downstream activation of migratory pathways. 
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6) METHOD DEVELOPMENT AND 
CONSIDERATIONS
Investigation of the Trojan horse hypothesis of T. gondii dissemination requires 
appropriate assays that model host cell migration under varying conditions (Chapter 3.4). 
The assays employed in this thesis to quantify cell motility and migration are discussed 
below. As all in vitro models, they represent attempts to mimic different facets of the in 
vivo setting under defined conditions. For more detailed descriptions of the methods 
and procedures employed in the different studies, the reader is referred to the methods 
sections of the respective papers.
6.1) Assays to Measure Cell Migration 
Motility Assay (paper III & IV)
This assay was developed to allow quantification of cell migration on a single cell level 
and to distinguish non-infected cells from T. gondii infected ones (Fig 4). Infection with 
fluorescent parasites is done in a 96 well format, after which the cells are embedded in 
a collagen I matrix and transferred to multiwell glass slides. Live cell imaging is then 
performed and cells are manually tracked to minimize errors associated with automated 
tracking solutions. During the optimization phase we defined optimal incubation volumes 
and times for the different steps, concentration of collagen, imaging intervals and tracking 
method. We then evaluated the reproducibility of the assay and found that DCs increase 
their velocity by a factor 2,9±0,9 upon infection in 12 experiments performed over a period 
of 6 months. Velocities of non-infected DCs in the motility assay are generally lower than 
what has been observed in vivo, although closer to DCs migrating in interstitial tissue than 
those in lymph nodes (163, 194). We conclude that, while the motility assay underestimates 
the motile capacity of DCs in vivo, it is a robust and useful assay to study the migratory 
activation of DCs and other cells upon T. gondii infection.
Transmigration Assay (paper I, II, III & IV)
The transmigration assay is performed in a chamber divided into a top and bottom 
compartment by a porous membrane, on which cells are deposited. Counting the number 
of cells in the lower compartment after a period of incubation gives the transmigration 
rate. The assay can be made to more closely model a biological barrier by coating the 
membrane with ECM components, e.g. collagen or matrigel, and/or a monolayer of cells, 
e.g. endothelial cells, astrocytes or BeWo (53, 160, Paper I). A potential drawback of the 
assay is the relatively long incubation times and binary output, compared to the motility 
assay.
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Chemotaxis Assay (paper II & III)
From the many assays described in the literature that measure chemotaxis, we prefer a 
commercially available system set in microfabricated channels on a glass slide (μ-Slide, 
Ibidi). The arrangement of two perpendicular channels, one containing the cell suspension 
and the other a chemokine gradient, admits superior control of gradient formation 
compared to commonly used Boyden chamber systems.
Adoptive Transfers and Bioluminescence Imaging (paper II)
To evaluate the impact of different factors on T. gondii Trojan horse dissemination in vivo, 
we adoptively transfer cells infected in vitro with parasite strains expressing luciferase. 
Parasite dissemination and replication is followed through bioluminescence imaging 
(IVIS, PerkinElmer), allowing repeated observations of the same animals in contrast 
to plaquing assays (68). On the level of individual organs, however, the plaquing assay 
remains a more sensitive technique due to the lower detection threshold of replicating 
parasites (Paper II).
FIGURE 4. Motility assay work flow. Graphical representation of the steps from 
experimental setup to cell tracking and data analysis.
6.2) Defining the Hypermigratory Phenotype
Using the assays described above allows us to dissect the hypermigratory phenotype 
observed upon T. gondii infection into more precise terms. The increased velocity and 
transmigration rate observed in the motility and transmigration assays upon infection, 
we have termed “hypermotility” and “hypermigration” respectively. Also, infected DCs 
acquire the capacity to chemotax along a CCR7 gradient (Chapter 3.3). Importantly, 
infection of DCs promotes parasite dissemination in vivo, which can be linked to in vitro 
hypermigration, hypermotility and chemotaxis by pharmacological studies (160, 161, 
Paper II). The hypermigratory phenotype can thus be defined as presenting as subset or 
all of these traits collectively (325).
Experimental setup and 
incubation in 96-well 
format.
Collagen embedding 
and loading onto sealed 
chamber slides.
Live multichannel 
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7) CONCLUSIONS AND FUTURE 
PERSPECTIVES
The requirement for tachyzoite dissemination from the small intestine to distant sites 
where pathology develops is a prerequisite for clinical manifestations of T. gondii 
infection, e.g. chorioretinitis (the eye), congenital toxoplasmosis (the placenta) and 
toxoplasmic encephalitis (the brain). Having previously confirmed the disseminatory 
advantage given by the hypermigratory phenotype in vivo, we here modeled this process 
using different in vitro approaches. A key step in understanding T. gondii dissemination 
will be the linking of different aspects observed in vitro, e.g. morphological alterations, 
hypermotility, hypermigration and chemotaxis, to corresponding cellular activities in vivo. 
The differential regulation of these traits, indicated by our results, suggests that they could 
be selectively targeted in therapeutic strategies. This would however require knowledge of 
which processes actually mediate the enhanced dissemination observed in vivo. Similarly, 
the impact of the proposed Trojan horse mediated local dissemination in the CNS on the 
clinical course of toxoplasmic encephalitis should be evaluated. 
The work presented in this thesis features a GABAergic-Ca2+ signaling axis previously 
undescribed in DCs. While several of its components have been associated to migratory 
properties in other cell types, the role of this pathway in basal DC migration remains to be 
studied. As Ca2+ signaling modulates cellular motility on many different levels, dissecting 
the cascades downstream of GABAergic activation is challenging. Simultaneous work to 
identify T. gondii derived factors that participate in the initiation of the hypermigratory 
phenotype will likely facilitate this task. From a therapeutic perspective, the implication 
of GABA receptors and VDCCs in T. gondii dissemination is interesting, since these have 
been successfully studied as drug targets. Two compounds that were found to inhibit the 
hypermigratory phenotype in Paper IV, nifedipine and verapamil, have been used to treat 
hypertension since the 1970s and 80s respectively.  
Work by us and others have described a role for GABA in regulating the immune system. 
The term ”neuroimmunotransmitter” has been proposed to denominate the growing class 
of signal transducers that relay information both in the CNS and in the immune system 
(170). In the specific case of GABA, however, it is important to note that while it has been 
widely studied as a neurotransmitter in the vertebrate CNS, it has been described in 
prokaryotes, plants, fungi and protozoa (34, 152, 172, 331). Being a simple γ-amino acid 
that is interconvertible with key metabolic molecules such as glutamate and oxaloacetate, 
the apparent evolutionary retention of GABA is not surprising. Whether this ubiquitous 
presence may enable interactions across species, e.g. between commensal or parasitic 
organisms and their hosts, remains to be investigated. However, this could provide a new 
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dimension to the expression of GABA receptors on a variety of immune cells.
Finally, T. gondii has been employed as a model for other apicomplexan parasites for over 
15 years (145). This thesis has examined potential mechanisms of T. gondii dissemination. 
In the light of the hypermigratory phenotype, this parasite could also be considered as a 
tool for studying motility and migration of immune cells.
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